Responsive polymers and smart materials adapt to stimuli, providing solutions to drug delivery, tissue engineering, and even ...
Kivu Bioscience, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for difficult-to-treat cancers, today announced that the first patient has been dosed ...
Caregivers Butterfly Garden Good Neighbor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback